Published in J Immunol on April 01, 1997
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst (2009) 2.55
Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest (2002) 2.50
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med (2004) 1.96
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
PECAM-1: conflicts of interest in inflammation. Life Sci (2010) 1.30
Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol (1999) 1.29
Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice. Am J Pathol (2009) 1.18
Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis. Mol Biol Cell (2012) 1.11
PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol (2006) 1.11
Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem J (2002) 1.05
Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS One (2009) 1.04
Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J (2001) 0.92
Local oxidative stress expansion through endothelial cells--a key role for gap junction intercellular communication. PLoS One (2012) 0.90
ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med (2009) 0.88
Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. J Thromb Haemost (2010) 0.86
Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells. Br J Pharmacol (2013) 0.84
Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med (2011) 0.83
Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells. Mol Pharmacol (2009) 0.83
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol (2016) 0.83
Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity. J Cell Biol (1997) 0.82
Antithrombotic actions of statins involve PECAM-1 signaling. Blood (2013) 0.80
Automated quantification reveals hyperglycemia inhibits endothelial angiogenic function. PLoS One (2014) 0.78
Cardiovascular repair with bone marrow-derived cells. Blood Res (2013) 0.77
PECAM-1 gene polymorphism (rs668) and subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Balkan J Med Genet (2016) 0.77
Synthesis and evaluation of the aldolase antibody-derived chemical-antibodies targeting α5β1 integrin. Mol Pharm (2012) 0.76
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight (2016) 0.76
Protective Effect of Boiled and Freeze-dried Mature Silkworm Larval Powder Against Diethylnitrosamine-induced Hepatotoxicity in Mice. J Cancer Prev (2016) 0.75
Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function. Chem Biol Interact (2010) 0.75
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol (1995) 3.34
Epidermal Langerhans cells bear Fc and C3 receptors. Nature (1977) 3.21
Diagnostic accuracy of dermoscopy. Lancet Oncol (2002) 3.14
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol (2000) 2.75
Impact of landscape management on the genetic structure of red squirrel populations. Science (2001) 2.34
Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28
Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol (1987) 1.90
Ecstasy pill testing: harm minimization gone too far? Addiction (2001) 1.85
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol (1998) 1.82
The fine structure of the Langerhans cell granule. J Cell Biol (1967) 1.79
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet (2000) 1.68
The langerhans cell. Curr Probl Dermatol (1972) 1.67
Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol (1988) 1.62
Methadone maintenance and tuberculosis treatment. BMJ (1996) 1.61
Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol (1991) 1.60
Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J Immunol (1981) 1.60
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol (1997) 1.60
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med (1990) 1.57
Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. J Invest Dermatol (1975) 1.57
Uptake, intracellular transport and degradation of exogenous protein by Langerhans cells. An electron microscopic-cytochemical study using peroxidase as tracer substance. J Invest Dermatol (1970) 1.56
Permeability of the epidermis and the phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as a marker. J Ultrastruct Res (1971) 1.55
[Odland bodies (Membrane coating granules, keratinosomes) as epidermal lysosomes. An electron microscopic-cytochemical contribution on the cornification process of the skin]. Arch Klin Exp Dermatol (1967) 1.51
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med (1998) 1.50
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine. Eur J Cancer (1998) 1.48
Treatment of psoriatic arthritis by extracorporeal photochemotherapy. Br J Dermatol (1990) 1.47
Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem (1998) 1.47
Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol (1991) 1.43
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol (1987) 1.42
Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions. J Am Acad Dermatol (1993) 1.41
Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol (1998) 1.41
Substance misuse among health care workers: national survey of occupational physicians. Occup Med (Lond) (2012) 1.40
[Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)]. Dtsch Med Wochenschr (1975) 1.38
Molecular analysis of plant migration and refugia in the Arctic. Science (2000) 1.37
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36
Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department. J Accid Emerg Med (1999) 1.35
MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol (1997) 1.32
Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol (1967) 1.31
[The Langerhans cells. Results of newer experimental studies. I]. Arch Klin Exp Dermatol (1967) 1.30
Langerhans cells as stimulator cells in the murine primary epidermal cell-lymphocyte reaction: alteration by UV-B irradiation. J Invest Dermatol (1982) 1.30
Langerhans' cells are an actual site of HIV-1 replication. Intervirology (1988) 1.27
P45, an extracellular 45 kDa protein of Listeria monocytogenes with similarity to protein p60 and exhibiting peptidoglycan lytic activity. Arch Microbiol (2000) 1.27
Generalized atrophic benign epidermolysis bullosa. Arch Dermatol (1982) 1.27
An electron microscopic study on the extraneous coat of keratinocytes and the intercellular space of the epidermis. J Invest Dermatol (1968) 1.24
Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol (1967) 1.22
Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes. Br J Clin Pharmacol (1999) 1.21
Ultrastructural localization of pemphigus autoantibodies within e epidermis. Nature (1971) 1.21
Cannabis use in patients with multiple sclerosis. Mult Scler (2006) 1.21
Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells. J Immunol (1983) 1.20
Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol (1978) 1.20
In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Am Acad Dermatol (1987) 1.19
Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol (2000) 1.17
Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J Invest Dermatol (1981) 1.17
[The permeability of the intercellular space of the epidermis for low molecular weight protein. Electron microscopic cytochemical studies with peroxidase as a tracer substance]. Arch Klin Exp Dermatol (1969) 1.17
Photoprotective effect of a psoralen-UVA-induced tan. Arch Dermatol Res (1978) 1.17
Interleukin 2 receptors on cultured murine epidermal Langerhans cells. J Immunol (1986) 1.16
Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res (2001) 1.16
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin. J Invest Dermatol (1986) 1.16
[Uptake, intracellular transport, and degradation of exogenous protein by keratinocytes. Electron microscopy and cytochemical study using peroxidase as a tracer substance]. Arch Klin Exp Dermatol (1969) 1.15
MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol (1993) 1.15
Epidermal lysosomes. Electron microscopic-cytochemical studies. Arch Dermatol (1970) 1.15
Generalized eruptive histiocytoma. Enzyme histochemistry and electron microscopy. Arch Dermatol (1967) 1.14
The use of solid-phase radioimmunoassay techniques for serodiagnosis of human plague infection. Bull Pan Am Health Organ (1980) 1.13
In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol (1993) 1.11
Novel Ras antagonist blocks human melanoma growth. Proc Natl Acad Sci U S A (1999) 1.10
The disappearance and regeneration of Langerhans cells following epidermal injury. J Invest Dermatol (1968) 1.10
Phagocytosis of latex beads by epidermal keratinocytes in vivo. J Ultrastruct Res (1972) 1.08
Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period. J Immunol (1989) 1.07
The Langerhans cell. J Invest Dermatol (1983) 1.06
Experimental staphylococcal toxic epidermal necrolysis (TEN) in adult humans and mice. J Lab Clin Med (1974) 1.05
Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol (1998) 1.05
A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res (2001) 1.04
Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol (1996) 1.04
Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin. J Invest Dermatol (1975) 1.04
Sulfone treatment of granuloma annulare. J Am Acad Dermatol (1985) 1.03
[On the autoradiographic labelling of Langerhans cells with H3-thymidine]. Arch Klin Exp Dermatol (1967) 1.03
Intra-epidermal eccrine poroma: a histochemical and enzyme-histochemical study. Cancer (1969) 1.02
Improvement of the diagnostic accuracy in pigmented skin lesions by epiluminescent light microscopy. Anticancer Res (1987) 1.02
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. Mol Med (2000) 1.01
Hepatocellar hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Lab Invest (1975) 1.01
The giant melanosome: a model of deranged melanosome-morphogenesis. J Ultrastruct Res (1974) 0.99
Elevated procaspase levels in human melanoma. Melanoma Res (2001) 0.99
[Systemic nevomatosis: hairy nevus, multiple eruptive nevi and nevus-cell metastasis in lymph nodes]. Hautarzt (1974) 0.99
Necrobiosis lipoidica: treatment with systemic corticosteroids. Br J Dermatol (1992) 0.98
Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light microscopic observation. Lab Invest (1976) 0.98
5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis. Br J Dermatol (1979) 0.98
[Acantholysis. I. Pathomechanism of the cantharidine "acantholysis". An electron microscopic study]. Arch Klin Exp Dermatol (1968) 0.97
Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev (1998) 0.97
Differential expression of class II alloantigens by keratinocytes in disease. J Invest Dermatol (1987) 0.97
The phenotypic spectrum of histiocytosis X cells. J Invest Dermatol (1988) 0.97
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol (2001) 0.96
Solid-cystic hidradenoma of the skin. Clinical and histopathologic study. Arch Dermatol (1968) 0.96
PUVA-treatment of urticaria pigmentosa. Br J Dermatol (1978) 0.96